Omega Fund: Arcutis Biotherapeutics, Inc.: Arcutis Announces the Completion of $94.5 million Series C Financing
HBM Healthcare Investments, Vivo Capital, BlackRock, Omega Funds, Pivotal BioVentures, and Goldman Sachs join existing investors Frazier Healthcare Partners, Bain Capital Life Sciences, OrbiMed an...
Read full article »
Omega Fund is a venture capital firm that invests in biotech, medtech, diagnostics, services and healthcare Information technology companies.
Read more